<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02175836</url>
  </required_header>
  <id_info>
    <org_study_id>17/25-10-2006</org_study_id>
    <secondary_id>APRET, Athens Medical School</secondary_id>
    <nct_id>NCT02175836</nct_id>
  </id_info>
  <brief_title>Arrhythmia Prediction Trial</brief_title>
  <acronym>APRET</acronym>
  <official_title>Arrhythmia Prediction Trial and Risk Stratification in Heart Failure Patients - Athens.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Athens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with Ischaemic and Dilated Cardiomyopathy, face an increased risk for Arrhythmic
      Sudden Cardiac Death. The purpose of this study is to estimate the performance of Modern
      Non-Invasive Indices and the performance of Programmed Ventricular Stimulation in Sudden
      Cardiac Death Prediction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sudden Cardiac Death (SCD) threatens survival of Coronary Artery Disease and Dilated
      Cardiomyopathy patients with Heart Failure. Discovering efficient SCD risk stratification
      markers is of high importance. In this study, heart failure patients will be risk stratified
      with indices from the Myocardial substrate (QRS, fragmented QRS, Late potentials, LVEF),
      indices from the Repolarization status (QT duration, QT rate corrected , QT dispersion,
      QT/RR, T wave Amplitude Variability, T wave alternans, QT Variability Index), indices from
      the Autonomic Nervous System function [ Heart Rate variability, Heart rate Turbulence,
      Deceleration Capacity (DC) , DC sign of fraction, Beat to Beat DC, Non linear indices of
      Heart Rate Dynamics], the Non sustained ventricular tachycardia and Ventricular extrasystolic
      activity and the Circadian Properties of Heart Rate observed during Ambulatory Monitoring.
      Furthermore Programmed Ventricular Stimulation will be used. High resolution 30 min ECG
      recordings will performed for further indices research and development. All the Arrhythmic
      Risk Stratifiers will be analysed and their performance for Sudden Cardiac Death Prediction
      and for Total Mortality will be estimated according the follow up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sudden Cardiac Death surrogates: 1.Clinical Ventricular Tachyarrhythmia, 2.ICD's appropriate activation, 3.Confirmed Sudden Cardiac Death</measure>
    <time_frame>2007-2019 (12 years)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Mortality</measure>
    <time_frame>2007-2019 (12 years)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Dilated Cardiomyopathy</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>SCD possitive versus SCD negative group</arm_group_label>
    <description>The total Heart Failure patients subgroup experiencing Sudden Cardiac Death surrogate end-points during follow up versus the patients subgroup that is free from Sudden Cardiac Death surrogate end-points.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Heart Failure Patients with Myoacardial Infarction and Dilated Cardiomyopathy maintaining
        sinus rhyhtm.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Myocardial Infarction

          -  Dilated Cardiomyopathy

          -  Sinus rhythm

        Exclusion Criteria:

          -  Malignant diseases seriously affecting the survival

          -  Conditions/diseases affecting the Autonomic Nervous System's function

          -  Dementia

          -  Alcoholism

          -  Psychiatric diseases

          -  Addiction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>82 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Petros Arsenos, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Department of Cardiology, Medical School, National &amp; Kapodistrian University of Athens, Greece</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Petros Arsenos, MD, PhD</last_name>
    <phone>00306974338896</phone>
    <email>arspetr@otenet.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>First Department of Cardiology, Medical School, National &amp; Kapodistrian University of Athens</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petros Arsenos, MD, PhD</last_name>
      <phone>00306974338896</phone>
      <email>arspetr@otenet.gr</email>
    </contact>
    <investigator>
      <last_name>Petros Arsenos, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <link>
    <url>http://www.researchgate.net/profile/Petros_Arsenos?ev=hdr_xprf</url>
  </link>
  <reference>
    <citation>Mirowski M, Mower MM, Langer A, Heilman MS, Schreibman J. A chronically implanted system for automatic defibrillation in active conscious dogs. Experimental model for treatment of sudden death from ventricular fibrillation. Circulation. 1978 Jul;58(1):90-4.</citation>
    <PMID>647893</PMID>
  </reference>
  <reference>
    <citation>Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877-83. Epub 2002 Mar 19.</citation>
    <PMID>11907286</PMID>
  </reference>
  <reference>
    <citation>Bauer A, Barthel P, Schneider R, Ulm K, Müller A, Joeinig A, Stich R, Kiviniemi A, Hnatkova K, Huikuri H, Schömig A, Malik M, Schmidt G. Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J. 2009 Mar;30(5):576-83. doi: 10.1093/eurheartj/ehn540. Epub 2008 Dec 23.</citation>
    <PMID>19109245</PMID>
  </reference>
  <reference>
    <citation>Arsenos P, Gatzoulis KA, Dilaveris P, Gialernios T, Sideris S, Lazaros G, Archontakis S, Tsiachris D, Kartsagoulis E, Stefanadis C. The rate-corrected QT interval calculated from 24-hour Holter recordings may serve as a significant arrhythmia risk stratifier in heart failure patients. Int J Cardiol. 2011 Mar 3;147(2):321-3. doi: 10.1016/j.ijcard.2010.12.076. Epub 2011 Jan 15.</citation>
    <PMID>21239068</PMID>
  </reference>
  <reference>
    <citation>Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):504-12. doi: 10.1161/CIRCEP.113.000216. Epub 2013 Apr 15.</citation>
    <PMID>23588627</PMID>
  </reference>
  <reference>
    <citation>Arsenos P, Gatzoulis KA, Gialernios T, Dilaveris P, Tsiachris D, Archontakis S, Vouliotis AI, Raftopoulos L, Manis G, Stefanadis C. Elevated nighttime heart rate due to insufficient circadian adaptation detects heart failure patients prone for malignant ventricular arrhythmias. Int J Cardiol. 2014;172(1):e154-6. doi: 10.1016/j.ijcard.2013.12.075. Epub 2013 Dec 28.</citation>
    <PMID>24411917</PMID>
  </reference>
  <reference>
    <citation>Gatzoulis KA, Archontakis S, Dilaveris P, Tsiachris D, Arsenos P, Sideris S, Stefanadis C. Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part I: malignant ventricular arrhythmias. Hellenic J Cardiol. 2011 Nov-Dec;52(6):525-35. Review.</citation>
    <PMID>22143016</PMID>
  </reference>
  <reference>
    <citation>Gatzoulis KA, Tsiachris D, Dilaveris P, Archontakis S, Arsenos P, Vouliotis A, Sideris S, Trantalis G, Kartsagoulis E, Kallikazaros I, Stefanadis C. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work? Int J Cardiol. 2013 Aug 20;167(4):1360-5. doi: 10.1016/j.ijcard.2012.04.005. Epub 2012 Apr 24.</citation>
    <PMID>22534047</PMID>
  </reference>
  <reference>
    <citation>Huikuri HV, Mäkikallio TH, Raatikainen MJ, Perkiömäki J, Castellanos A, Myerburg RJ. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation. 2003 Jul 8;108(1):110-5. Review.</citation>
    <PMID>12847054</PMID>
  </reference>
  <reference>
    <citation>Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J. 2005 Apr;26(8):762-9. Epub 2005 Mar 18.</citation>
    <PMID>15778204</PMID>
  </reference>
  <reference>
    <citation>Wellens HJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, Huikuri HV, Kääb S, La Rovere MT, Malik M, Myerburg RJ, Simoons ML, Swedberg K, Tijssen J, Voors AA, Wilde AA. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014 Jul 1;35(25):1642-51. doi: 10.1093/eurheartj/ehu176. Epub 2014 May 5.</citation>
    <PMID>24801071</PMID>
  </reference>
  <reference>
    <citation>Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol. 2001 Mar;12(3):369-81. Review.</citation>
    <PMID>11291815</PMID>
  </reference>
  <reference>
    <citation>Gomes JA, Cain ME, Buxton AE, Josephson ME, Lee KL, Hafley GE. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation. 2001 Jul 24;104(4):436-41.</citation>
    <PMID>11468206</PMID>
  </reference>
  <reference>
    <citation>Merchant FM, Zheng H, Bigger T, Steinman R, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Klersy C, Chan PS, Bartone C, Hohnloser SH, Ruskin JN, Armoundas AA. A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification. Am Heart J. 2013 Oct;166(4):744-52. doi: 10.1016/j.ahj.2013.06.023. Epub 2013 Sep 18. Review.</citation>
    <PMID>24093856</PMID>
  </reference>
  <reference>
    <citation>Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation. 1978 Jun;57(6):1074-7.</citation>
    <PMID>639227</PMID>
  </reference>
  <reference>
    <citation>Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, Noullett C, Van Schaik A, Mitchell RT, Shibata MA, Gulamhussein S, McMeekin J, Tymchak W, Schnell G, Gillis AM, Sheldon RS, Fick GH, Duff HJ; REFINE Investigators. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. 2007 Dec 11;50(24):2275-84. Epub 2007 Nov 26.</citation>
    <PMID>18068035</PMID>
  </reference>
  <reference>
    <citation>Schwartz PJ. The autonomic nervous system and sudden death. Eur Heart J. 1998 Jun;19 Suppl F:F72-80. Review.</citation>
    <PMID>9651739</PMID>
  </reference>
  <reference>
    <citation>Bauer A, Barthel P, Müller A, Ulm K, Huikuri H, Malik M, Schmidt G. Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials. J Electrocardiol. 2009 Nov-Dec;42(6):597-601. doi: 10.1016/j.jelectrocard.2009.07.013.</citation>
    <PMID>19853731</PMID>
  </reference>
  <reference>
    <citation>De Ferrari GM, Rordorf R, Frattini F, Petracci B, De Filippo P, Landolina M. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator. Europace. 2007 Dec;9(12):1151-7. Epub 2007 Oct 17.</citation>
    <PMID>17947251</PMID>
  </reference>
  <reference>
    <citation>Huikuri HV, Raatikainen MJ, Moerch-Joergensen R, Hartikainen J, Virtanen V, Boland J, Anttonen O, Hoest N, Boersma LV, Platou ES, Messier MD, Bloch-Thomsen PE; Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction study group. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J. 2009 Mar;30(6):689-98. doi: 10.1093/eurheartj/ehn537. Epub 2009 Jan 20.</citation>
    <PMID>19155249</PMID>
  </reference>
  <reference>
    <citation>Gatzoulis KA, Archontakis S, Dilaveris P, Tsiachris D, Arsenos P, Sideris S, Stefanadis C. Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part II: potentially malignant and benign ventricular arrhythmias. Hellenic J Cardiol. 2012 May-Jun;53(3):217-33. Review.</citation>
    <PMID>22653247</PMID>
  </reference>
  <reference>
    <citation>Arsenos P, Gatzoulis K, Manis G, Gialernios T, Dilaveris P, Tsiachris D, Archontakis S, Kartsagoulis E, Mytas D, Stefanadis C. Decreased scale-specific heart rate variability after multiresolution wavelet analysis predicts sudden cardiac death in heart failure patients. Int J Cardiol. 2012 Feb 9;154(3):358-60. doi: 10.1016/j.ijcard.2011.11.007. Epub 2011 Nov 30.</citation>
    <PMID>22133464</PMID>
  </reference>
  <reference>
    <citation>Arsenos P, Gatzoulis K, Dilaveris P, Manis G, Tsiachris D, Archontakis S, Vouliotis AI, Sideris S, Stefanadis C. Arrhythmic sudden cardiac death: substrate, mechanisms and current risk stratification strategies for the post-myocardial infarction patient. Hellenic J Cardiol. 2013 Jul-Aug;54(4):301-15. Review. Erratum in: Hellenic J Cardiol. 2015 May-Jun;56(3):273. Vouliotis, Apostolis H [corrected to Vouliotis, Apostolos-Ilias].</citation>
    <PMID>23912922</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2014</study_first_submitted>
  <study_first_submitted_qc>June 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>January 27, 2016</last_update_submitted>
  <last_update_submitted_qc>January 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Athens</investigator_affiliation>
    <investigator_full_name>PETROS ARSENOS</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Arrhythmic Sudden Cardiac Death</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Risk Stratification</keyword>
  <keyword>Autonomic Nervous System</keyword>
  <keyword>Heart Rate</keyword>
  <keyword>Repolarization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

